Hong Kong-listed innovative pharmaceutical 50ETF rose more than 4%

Hong Kong Stock Innovation Medicine 50 ETF rose more than 4%, with a trading volume of 5.81 billion yuan. The fund's share has increased by 7 million in the past month, and the fund supports T+0 trading.